25 LLC’s Innoviva INVA Stock Holding History

25 LLC’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41	Closed	-$511	–	265
2023 Q2	$511	Buy	+41	New	+$513	﹤0.01%	517

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

25 LLC's INVA Position: Q3 2023 in Review

25 LLC sold out of Innoviva (INVA) in Q3 2023, closing a stake of 41 shares — an estimated $511 sold.

25 LLC first reported a position in INVA in Q2 2023 and held it in 1 quarter. The position peaked at $511 in Q2 2023. 193 funds tracked by Wall St. Rank hold INVA as of Q3 2023.

25 LLC reported no remaining Innoviva position as of Q3 2023 after selling out during the quarter.
25 LLC sold 41 Innoviva shares in Q3 2023, an estimated $511.
25 LLC first reported a position in Innoviva in Q2 2023 and held it in 1 quarter.
25 LLC's Innoviva position peaked at $511 in Q2 2023.
193 funds tracked by Wall St. Rank held Innoviva as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.